|
ERO1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
5.05130000050258E-07 |
| Normal-vs-Stage3 |
5.63390001317998E-09 |
| Normal-vs-Stage4 |
9.8972000039943E-08 |
| Stage1-vs-Stage2 |
5.421000E-01 |
| Stage1-vs-Stage3 |
9.583800E-01 |
| Stage1-vs-Stage4 |
7.259600E-01 |
| Stage2-vs-Stage3 |
6.696200E-01 |
| Stage2-vs-Stage4 |
8.572000E-01 |
| Stage3-vs-Stage4 |
8.183000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
5.90759999999912E-05 |
| Normal-vs-Asian |
6.362400E-02 |
| Caucasian-vs-AfricanAmerican |
1.368350E-02 |
| Caucasian-vs-Asian |
8.842000E-01 |
| AfricanAmerican-vs-Asian |
4.379400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62470037423645E-12 |
| Normal-vs-Female |
6.99440505513849E-15 |
| Male-vs-Female |
5.844400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.244900E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.021530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.306600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.977400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.572800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.808800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.922600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.030000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.213670E-04 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
1.71596070686064E-12 |
| Normal-vs-Grade 4 |
3.62810000043012E-07 |
| Grade 1-vs-Grade 2 |
5.797000E-01 |
| Grade 1-vs-Grade 3 |
1.900440E-01 |
| Grade 1-vs-Grade 4 |
3.342000E-01 |
| Grade 2-vs-Grade 3 |
7.859700E-02 |
| Grade 2-vs-Grade 4 |
6.551400E-01 |
| Grade 3-vs-Grade 4 |
4.902600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.87547763377916E-14 |
| ccA subtype-vs-ccB subtype |
4.876600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.802480E-02 |
| N0-vs-N1 |
4.405400E-01 |
|
|
